Revilico is an end-to-end drug discovery platform that bridges computational modeling and experimental validation. By combining industry leading AI, physics-driven software, and a robust wet lab marketplace, we streamline the entire drug development pipeline.
Our platform integrates generative chemistry, molecular dynamics, and deep learning with seamless access to experimental validation. This fusion enables researchers to move from theoretical designs to wet lab results with unmatched speed and efficiency, drastically reducing the time and cost of pharmaceutical development.
Revilico empowers scientists to identify meaningful disease targets, screen billions of molecules for ideal safety and efficacy, identify and optimize promising therapeutic candidates, design and optimize lead compounds, and bring transformative therapies to market faster than ever before.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Los Angeles, California 90024, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://revilico.bio/
- Keywords
- ML Modeling, Biotechnology Research, Data Analytics, Biotech AI Integration, Pharmaceutical Development, Drug Repurposing.
- HQ
- Los Angeles, California
Revilico Inc. Questions
Revilico Inc.'s website is https://revilico.bio/
Revilico Inc.'s LinkedIn profile is https://www.linkedin.com/company/revilicoinc
Revilico Inc. has
11 employees.
View email and phone details for 11
employees at Revilico Inc..
Revilico Inc.'s industry is
Biotechnology Research
Revilico Inc.'s top competitors are
Forum Ventures,
Perto,
Onelab Ventures,
Max Biopharma, Inc.,
Momentum Ai,
Biomark Oncology,
Top Predictor,
Nucleate Los Angeles,
Alnylam Pharmaceuticals,
Cogenesis, Inc..
Revilico Inc.'s categories are Biotechnology Research
Revilico Inc.'s founding year is 2023
